/antagonists & inhibitors. /antagonists and inhibitors . /antagonists . /inhibitors . Used with chemicals, drugs, and endogenous substances to indicate substances or agents which counteract their biological effects by any mechanism. . 1.00
Androgen Antagonists. Anti-Androgen Effect . Anti-Androgen Effects . Antiandrogen Effect . Antiandrogen Effects . Antagonists, Androgen . Anti Androgen Effect . Anti Androgen Effects . Effect, Anti-Androgen . Effect, Antiandrogen . Effects, Anti-Androgen . Effects, Antiandrogen . Antiandrogens . Compounds which inhibit or antagonize the biosynthesis or actions of androgens. . 0.65
Angiotensin-Converting Enzyme Inhibitors. Angiotensin I-Converting Enzyme Inhibitors . Angiotensin-Converting Enzyme Antagonists . Antagonists, Angiotensin-Converting Enzyme . Antagonists, Kininase II . Inhibitors, ACE . Inhibitors, Angiotensin-Converting Enzyme . Inhibitors, Kininase II . Kininase II Antagonists . Angiotensin Converting Enzyme Antagonists . Angiotensin Converting Enzyme Inhibitors . Angiotensin I Converting Enzyme Inhibitors . Antagonists, Angiotensin Converting Enzyme . Enzyme Antagonists, Angiotensin-Converting . Enzyme Inhibitors, Angiotensin-Converting . Inhibitors, Angiotensin Converting Enzyme . Kininase II Inhibitors . ACE Inhibitors . A class of drugs whose main indications are the treatment of hypertension and heart failure. They exert their hemodynamic effect mainly by inhibiting the renin-angiotensin system. They also modulate sympathetic nervous system activity and increase prostaglandin synthesis. They cause mainly vasodilation and mild natriuresis without affecting heart rate and contractility. . 0.60
Adenosine Deaminase Inhibitors. ADA Inhibitors . Deaminase Inhibitors, Adenosine . Inhibitors, ADA . Inhibitors, Adenosine Deaminase . Drugs that inhibit ADENOSINE DEAMINASE activity. . 0.58
Androgen Receptor Antagonists. Antagonists, Androgen Receptor . Receptor Antagonists, Androgen . Compounds that bind to and inhibit the activation of ANDROGEN RECEPTORS. . 0.57